+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

From
From
From
From
PSMA - Targeted Therapy Pipeline Review - Product Thumbnail Image

PSMA - Targeted Therapy Pipeline Review

  • Report
  • May 2024
  • Global
From
Gynaecology Drugs Market Report 2023-2033 - Product Thumbnail Image

Gynaecology Drugs Market Report 2023-2033

  • Report
  • February 2023
  • 340 Pages
  • Global
From
From
From
Global Proto Oncogene Market & Clinical Pipeline Insight 2024 - Product Thumbnail Image

Global Proto Oncogene Market & Clinical Pipeline Insight 2024

  • Drug Pipelines
  • February 2018
  • 440 Pages
  • Global
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
From
Markets at a Glance: Pharmaceuticals - Product Thumbnail Image

Markets at a Glance: Pharmaceuticals

  • Report
  • May 2019
  • 115 Pages
  • Global
From
Lyophilisation in Pharmaceutical Market Report 2023-2033 - Product Thumbnail Image

Lyophilisation in Pharmaceutical Market Report 2023-2033

  • Report
  • November 2022
  • 260 Pages
  • Global
From
From
From
From
From
From
Checkpoint Inhibitors - Competitive landscape, 2023 - Product Thumbnail Image

Checkpoint Inhibitors - Competitive landscape, 2023

  • Report
  • April 2023
  • 350 Pages
  • Global
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more